Superworth

Veracyte PE ratio VCYT

Share price divided by earnings per share over the last twelve months, since 2025.

Today, Nov 2, 2026
35.0×
Peer median
41.2×

Veracyte's PE ratio is 35.0× as of Nov 2, 2026: a share price of $49.00 against $1.40 of earnings per share over the last twelve months.

The median for 10 diagnostics and research stocks of a similar size is 41.2×.

PE ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far35.0×28.4×112×
2025112×57.3×125×

Against its peers

Companies in Medical - Diagnostics & Research nearest Veracyte's size, closest first, today.

CompanyPE ratio
VCYTVeracyte35.0×
CDNACareDx35.9×
BLLNBillionToOne170×
LNTHLantheus24.3×
CAICaris Life Sciences86.8×
BIOBio-Rad Laboratories44.4×
RVTYRevvity72.2×
MEDPMedpace38.0×
DGXQuest Diagnostics24.9×
LHLabcorp29.4×
NRCNRC Health97.0×
Peer median41.2×

Where Veracyte ranks

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on Veracyte

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.